Roche is seeking damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker’s latest case targeting what the company calls fraudulent schemes involving its diabetes test strips.
Researchers at Indiana University developed a blood test that could help more accurately diagnose post-traumatic stress disorder.
Swiss drugmaker Roche upped the company’s bet on personalized cancer treatment and is ready to sell a blood test around the world that can identify common gene mutations from solid tumors from a patient’s blood.
EpicGenetics and Massachusetts General Hospital are launching a Phase II clinical trial to test a tuberculosis vaccine, CBG, as a potential treatment for fibromyalgia.
Israel’s Medial EarlySign, whose machine-learning based technology is meant to help improve patient management, said on Tuesday it raised $30 million, bringing its total funding to $50 million.
A new blood test from Roche and Foundation Medicine has shown it can accurately measure the number of mutations within a tumor, potentially helping doctors predict which patients may respond best to some immunotherapies.
Quest Diagnostics Inc. will use a more precise method of calculating levels of “bad” LDL cholesterol that no longer requires fasting prior to blood draw, a development likely to delight patients who previously had to refrain from eating for up to 12 hours before testing.
Theranos reached a settlement with the Centers for Medicare and Medicaid Services, which could make it eligible to operate a clinical lab within two years.
Theranos reportedly failed to notify patients in Arizona about potentially deficient diabetes tests.
A Bay Area hedge fund has filed a lawsuit against embattled Theranos alleging the company duped investors about the efficacy of its products in order to attract investments of nearly $100 million.